Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors
View Patent ↗Production of clinical grade gene therapy vectors for human trials remains a major hurdle in advancing cures for a number of otherwise incurable diseases. Disclosed herein are systems based on a stably trans formed insect cell lines harboring helper genes required for vector production. Specifically exemplified are system embodiments that take advantage of DNA regulatory elements from two unrelated viruses—AcMNPV and AA V2. System embodiments utilize rep and/or cap genes either stably transfected in cell lines or which are introduced into cells as an expression cassette in a vector. Rep and cap genes that are designed to remain silent until the cell is infected with a viral vector. Infection with viral initiates rescue/amplification of integrated AAV helper genes resulting in dramatic induction of the expression and assembly of rAAV. The arrangement of this specific embodiment provides high levels of Rep and Cap proteins in every cell thus improving rAAV yields by 10-fold. The described vectors are modular in design and may be utilized for the production of other multiprotein complexes.
1. An inducible protein expression system, said system comprising
a baculovirus expression vector (BEV) that comprises a BEV-immediate early transcriptional transactivator inducer element (IE-1) and an AAV rep gene, wherein expression of the IE-1 and the AAV rep gene is under control of an expression control element; and
an insect cell stably transformed with an expression cassette comprising
a gene of interest, operatively linked to a promoter, an hr2 0.9 element, and a rep-binding element (RBE);
wherein expression of said gene of interest is induced upon infection of said insect cell with said BEV.
2. The system of claim 1 , wherein the RBE element is upstream of the promoter.
3. The system of claim 1 , wherein said expression cassette is integrated into a genome of said cell.
4. The system of claim 1 , wherein said insect cell is an insect sf9 cell.
5. An inducible protein expression system, said system comprising
a baculovirus expression vector (BEV) that comprises a BEV immediate early transcriptional transactivator inducer element (IE-1) whose expression is under control of an expression control element; and
an insect cell stably transformed with an expression cassette comprising a gene of interest operatively linked to a promoter and an hr2 0.9 element;
wherein expression of the gene of interest is induced upon infection of said insect cell with said BEV and expression of the IE-1.
6. The system of claim 5 , wherein said insect cell is an insect sf9 cell.
7. An inducible protein expression system, said system comprising
a baculovirus expression vector (BEV) that comprises a BEV immediate early transactivator inducer element (IE-1), wherein expression of the IE-1 is under control of an expression control element; and
an insect cell stably transformed with an expression cassette comprising a gene of interest and a AAV rep gene operatively linked to a promoter, an hr2 0.9 element, and a rep-binding element (RBE), wherein expression of said rep gene and said gene of interest is induced upon infection of said insect cell with said BEV; and rescue and amplification of said expression cassette is induced upon expression of said rep gene.
8. The system of claim 7 , wherein said rep gene is upstream of said gene of interest.
9. The system of claim 7 , wherein said expression cassette is integrated into a genome of said insect cell and is rescued therefrom and amplified upon expression of said rep gene.